ibogaine has been researched along with Heroin Abuse in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 3 (33.33) | 24.3611 |
2020's | 2 (22.22) | 2.80 |
Authors | Studies |
---|---|
Gerona, R; Grogan, J; Kao, L; Snow, JW | 1 |
Anderson, EI; Brown, BM; Cameron, LP; Dunlap, LE; Ehinger, Y; Fiehn, O; Hurley, ZQ; Kokel, D; Laskowski, LJ; Lein, PJ; Liu, T; Lu, J; McCarroll, MN; McCorvy, JD; Myers-Turnbull, D; Olson, DE; Pell, AJ; Peters, J; Rabow, ZT; Ron, D; Taylor, JC; Tjia, M; Tombari, RJ; Vargas, MV; Viswanathan, J; Wulff, H; Yaghoobi, B; Zhang, G; Zuo, Y | 1 |
Aćimović, T; Atanasijević, T; Bogdanović, M; Denić, K; Lukić, V; Popović, V | 1 |
Bashir, Y; Hildyard, C; Macklin, P; Prendergast, B | 1 |
Nestor, J | 1 |
Daley, M; Fuller, BE; McCarty, D; Rieckmann, T; Thomas, CP | 1 |
Alper, KR; Bastiaans, J; Frenken, GM; Lotsof, HS; Luciano, DJ | 2 |
Ervin, FR; Hearn, WL; Kamlet, JD; Kovera, CA; Mash, DC; Pablo, J; Tyndale, R | 1 |
1 review(s) available for ibogaine and Heroin Abuse
Article | Year |
---|---|
Ibogaine in the treatment of heroin withdrawal.
Topics: Animals; Heroin Dependence; Humans; Ibogaine; Polymorphism, Genetic; Substance Withdrawal Syndrome | 2001 |
1 trial(s) available for ibogaine and Heroin Abuse
Article | Year |
---|---|
Treatment of acute opioid withdrawal with ibogaine.
Topics: Adult; Female; Hallucinogens; Heroin Dependence; Humans; Ibogaine; Injections, Intravenous; Male; Substance Withdrawal Syndrome; Treatment Outcome | 1999 |
7 other study(ies) available for ibogaine and Heroin Abuse
Article | Year |
---|---|
Ibogaine Consumption With Seizure-Like Episodes, QTc-Prolongation, and Captured Cardiac Dysrhythmias.
Topics: Adult; Arrhythmias, Cardiac; Excitatory Amino Acid Antagonists; Female; Heroin Dependence; Humans; Ibogaine; Long QT Syndrome; Seizures; Tabernaemontana | 2019 |
A non-hallucinogenic psychedelic analogue with therapeutic potential.
Topics: Alcoholism; Animals; Antidepressive Agents; Arrhythmias, Cardiac; Behavior, Addictive; Chemistry Techniques, Synthetic; Depression; Disease Models, Animal; Drug Design; Female; Hallucinogens; Heroin Dependence; Ibogaine; Male; Mice; Mice, Inbred C57BL; Neuronal Plasticity; Patient Safety; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Agonists; Substance-Related Disorders; Swimming; Tabernaemontana | 2021 |
Death due to consumption of ibogaine: case report.
Topics: Adult; Bridged-Ring Compounds; Fatal Outcome; Hallucinogens; Heroin Dependence; Humans; Ibogaine; Indole Alkaloids; Male | 2021 |
A Case of QT Prolongation and Torsades de Pointes Caused by Ibogaine Toxicity.
Topics: Adult; Electrocardiography; Excitatory Amino Acid Antagonists; Heroin Dependence; Humans; Ibogaine; Male; Self Medication; Torsades de Pointes | 2016 |
Get Clean or Die Trying.
Topics: Acetylcholine; Arrhythmias, Cardiac; Brain; Dopamine; Excitatory Amino Acid Antagonists; Female; Hallucinogens; Heart Arrest; Heroin Dependence; Humans; Ibogaine; Male; Serotonin; Substance-Related Disorders | 2016 |
Client and counselor attitudes toward the use of medications for treatment of opioid dependence.
Topics: Adult; Ambulatory Care; Attitude of Health Personnel; Buprenorphine; Clonidine; Counseling; Culture; Female; Focus Groups; Heroin Dependence; Humans; Ibogaine; Male; Methadone; Middle Aged; Narcotics; Opioid-Related Disorders; Patient Admission; Patient Satisfaction; Peer Group; Psychotropic Drugs; Substance Withdrawal Syndrome; Treatment Outcome | 2007 |
Ibogaine in acute opioid withdrawal. An open label case series.
Topics: Acute Disease; Female; Heroin Dependence; Humans; Ibogaine; Male; Substance Withdrawal Syndrome | 2000 |